STAT February 1, 2023
Mohana Ravindranath

The Federal Trade Commission on Wednesday accused GoodRx, the prescription drug discount platform, of sharing sensitive personal information about its users’ prescriptions and health conditions with big tech companies.

GoodRx, which also runs a marketplace for telehealth services, agreed to pay a $1.5 million civil penalty for sharing users’ health data — like medication use or health conditions — with third parties including Facebook, Google, and Twilio for advertising. The settlement marks the first time the FTC has taken action under its Health Breach Notification Rule, and comes as the federal government looks to crack down on consumer companies deceptively selling and sharing health data.

GoodRx collects sensitive information from users and from pharmacy benefit managers who confirm when a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Social Media, Technology
Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry
How Life Sciences Can Drive Innovation And Sustainability In Returns Management
Daiichi Sankyo Announces New CEO
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Duquesne, CVS debut tuition program to train pharmacists

Share This Article